Dr Frank Tomecek Receives Risk All Star Award

Dr Frank Tomecek Receives Risk All Star Award
Carlsbad, CA, September 15, 2014 --(PR.com)-- Emerge Diagnostics, is pleased to announce today that Frank Tomecek, MD, received the Risk All Star Award from Risk & Insurance for his groundbreaking work with Emerge Diagnostics. Risk All Stars stand out from their peers by overcoming challenges through creativity, passion, and perseverance. Dr. Tomecek exemplifies all these traits in his continual efforts to achieve better patient outcomes.

Frank J. Tomecek, MD, is a clinical associate professor of the Department of Neurosurgery for the University of Oklahoma College of Medicine-Tulsa. He has also served as chairman of the Neurology, Neurosurgery, Physical Medicine, Rehab and Pain Management section. Dr. Tomecek is cofounder of the Tulsa Spine and Specialty Hospital, Neurosurgeon at Oklahoma Spine and Brain Institute, and he also serves as a Medical Director and Advisor for Emerge Diagnostics.

"It has been an honor and a privilege to work with Dr. Tomecek. He is one of the most caring and brilliant doctors I have had the opportunity to work with. I am so excited about the ground breaking work we are forging on hardware removal techniques using the EFA. It was Dr. Tomecek's foresight and diligence that lead us to being better able to help in this specialized area of medicine," commented Mary Rose Reaston, Ph.D. Chief Science Officer and Founder of Emerge Diagnostics.

“We at Emerge are thrilled with this recognition for Dr. Tomecek, and look forward to his continued contribution to the development of Emerge Diagnostics in the future,” added Robert Thompson, CEO Emerge Diagnostics, “He is truly a Risk All Star.”

About Emerge Diagnostics:
Emerge Diagnostics is the developer and manufacturer of the proprietary device that performs the EFA, the Electro-diagnostics Functional Assessment, a diagnostic evaluation directed towards diagnosing soft-tissue injuries such as sprains/strains and cumulative trauma disorders. With the EFA at its core, the Emerge Soft Tissue Management program substantially reduces workers compensation claims costs through prevention of false claims, limiting claims to those arising out of the course and scope of employment, and through better treatment outcomes for work related injuries.
Emerge Diagnostics
Mary Reaston